It builds on previously published research which found the drug had "consistent benefits" on preventing heart attacks, strokes, and death due to cardiovascular causes in those with type 2 diabetes and chronic kidney disease
thus, protecting the welfare state from spending money on drugs not deemed to be cost-effective, while protecting patients against high costs by utilizing a maximum yearly expense [46]
Understanding GLP-1 Medications and Their Impact on Digestion Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the landscape of diabetes management and weight loss
Brain function in the elderly: role of vitamin B 12 and folate
Many psychiatrists already do, particularly for patients with antipsychotic-induced weight gain
44 , 46 Although 52-week data were reported, these networks were sparse, thus there may be greater uncertainty in the findings